atrasentan has been researched along with Follicular Thyroid Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donckier, JE; Flamion, B; Mertens-Strijthagen, J | 1 |
1 other study(ies) available for atrasentan and Follicular Thyroid Carcinoma
Article | Year |
---|---|
Role of the endothelin axis in the proliferation of human thyroid cancer cells.
Topics: Adenocarcinoma, Follicular; Aspartic Acid Endopeptidases; Atrasentan; Blotting, Western; Bromodeoxyuridine; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Endothelin A Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Humans; Immunoradiometric Assay; Metalloendopeptidases; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine; Thyroid Neoplasms | 2007 |